Abstract
We present a case of domperidone withdrawal in a woman using the medication as a galactagogue. Our primary goal is to increase the literature available to providers who work with women who are breastfeeding. We evaluated a woman presenting to our reproductive psychiatry clinic for consultation regarding anxiety and agitation in the context of domperidone discontinuation. We evaluated the available literature regarding domperidone as a galactagogue, as well as the literature regarding adverse effects. The patient presented with withdrawal symptoms after gradual taper and discontinuation of domperidone. After restarting the medication, her symptoms resolved. She was able to successfully discontinue domperidone with a slow, gradual taper. Domperidone is occasionally used as a galactagogue in women with inadequate milk supply. We report a case in which a woman experienced withdrawal symptoms after domperidone discontinuation.
This is a preview of subscription content, log in via an institution to check access.
References
American Academy of Pediatrics (2012) Breastfeeding and the use of human milk. Pediatrics 129(3):e827–e841. https://doi.org/10.1542/peds.2011-3552.
Cerovecki A, Musil R, Klimke A et al (2013) Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations. CNS Drugs 27(7):545–572. https://doi.org/10.1007/s40263-013-0079-5
The Food and Drug Administration (2004) FDA talk paper: FDA warns against women using unapproved drug, domperidone, to increase milk production. https://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm173886.htm. Accessed 29 June 2017
Osadchy A, Moretti ME, Koren G (2012) Effect of domperidone on insufficient lactation in puerperal women: a systematic review and meta-analysis of randomized controlled trials. Obstet Gynecol Int 2012:642893. https://doi.org/10.1155/2012/642893
Papastergiou J, Abdallah M, Tran A, Folkins C (2013) Domperidone withdrawal in a breastfeeding woman. Can Pharm J CPJ 146(4):210–212. https://doi.org/10.1177/1715163513492928
Paul C, Zénut M, Dorut A et al (2015) Use of domperidone as a galactagogue drug: a systematic review of the benefit-risk ratio. J Hum Lact Off J Int Lact Consult Assoc 31(1):57–63. https://doi.org/10.1177/0890334414561265
Reddymasu SC, Soykan I, McCallum R (2007) Domperidone: review of pharmacology and clinical applications in gastroenterology. Am J Gastroenterol 102:2036–2045. https://doi.org/10.1111/j.1572-0241.2007.01255.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with animal or human participants performed by any of the authors.
Rights and permissions
About this article
Cite this article
Doyle, M., Grossman, M. Case report: domperidone use as a galactagogue resulting in withdrawal symptoms upon discontinuation. Arch Womens Ment Health 21, 461–463 (2018). https://doi.org/10.1007/s00737-017-0796-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-017-0796-8